Hypofractionated IMRT, Prostate Cancer, and Late ToxicitiesHypofractionated IMRT, Prostate Cancer, and Late Toxicities

Hypofractionated radiation has multiple advantages over the conventional approach, but it is still not widely used, and toxicities are a concern. A new study offers insights. Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news